Webinar
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
In Study Across 15 Centers, 35% of Patients With MCL See Progression After CAR T-Cell Therapy
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
GLP-1s’ Preoperative Use Requires Safety Considerations
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
Can Biomarkers Help Pinpoint the Right Treatment for Chronic Spontaneous Urticaria?
Switching to Gene Therapy After Nusinersen or Risdiplam May Benefit Patients With SMA